Previous studies have reported that the deletion of the Ctsb gene has a significant positive impact on behavioural deficits in conditions such as ischaemic neuropathic damage, inflammatory pain, opioid tolerance, epilepsy, and Alzheimer's disease [44]. Here, CTSB is linked to early-onset autosomal dominant Alzheimer disease.